# 22nd International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV

> **NIH NIH R13** · JOHNS HOPKINS UNIVERSITY · 2020 · $43,000

## Abstract

With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes
of death and disability in people living with HIV around the globe, including low and middle
income countries (LMIC). Large meetings, such as the Conference for Retroviruses and
Opportunistic Infections and the International AIDS Society Conference, are important venues
for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller,
more intimate formats that emphasize discussion and networking are critical to the career
development of HIV Comorbidity investigators. The International Workshop for Comorbidities
and Adverse Drug Reactions in HIV, now in its 22nd year, provides <200 delegates with an
opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity
research in one-room, two-day format. Plenary speakers are either noted experts from outside
of HIV research or HIV researchers with expertise in a specific comorbidity. Abstract
presentations including 24 15-minute talks and a poster session provide ample opportunity for
researchers to present and get feedback on their latest work. With this R13, we propose to
enhance the 22nd Workshop (September 12th/13th in New York) with the following aims: 1) to
provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships
to LMIC investigators, supporting an internationally-recognized expert in non-communicable
diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to
support early-stage investigators with a scholarship program and a research skill building
workshop, and guided poster tour, 3) to increase the impact of the Workshop through the
webcast of plenary and abstract presentations. By providing a “scientific home” to an increasing
number of HIV Comorbidity investigators from around the world, we hope to catalyze future
research efforts in HIV Comorbidities and facilitate the translation of research findings into
clinical strategies that can improve the lifespan and health span of PLWH.

## Key facts

- **NIH application ID:** 10082909
- **Project number:** 1R13AI155231-01
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** TODD T BROWN
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $43,000
- **Award type:** 1
- **Project period:** 2020-07-24 → 2021-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10082909

## Citation

> US National Institutes of Health, RePORTER application 10082909, 22nd International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV (1R13AI155231-01). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10082909. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*